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1.22 to 1.36), left ventricular rejection fraction (per 5% decrement from 45%; OR: 1.10; 95% CI: 1.06 to 1.14), age (per 10-year difference to 60 years; OR: 1.41; 95% CI: 1.34 to 1.49), atrial fibrillation (OR: 1.19; 95% CI: 1.06 to 1.34), and male sex (OR: 1.90; 95% CI: 1.67 to 2.17).
CONCLUSIONS SchlaHF registry data demonstrate a high prevalence of SDB in a representative population of stable patients with chronic HF receiving contemporary medical management. Male sex, age, body mass index, and the severity of both symptoms and left ventricular dysfunction were clinical predictors for prevalent SDB. However, a significant number of those with chronic HF still experience persistent symptoms, and most of them will die from cardiovascular causes, usually progressive HF (1, 2) . A complementary strategy assistance by an independent medical writer (Nicola Ryan Arzt et al.
The SchlaHF Registry Data for the management of HF might be to identify alternative and additional features that contribute to disease progression and impair prognosis, and then develop strategies to target, improve, and overcome these factors (5).
Sleep-disordered breathing (SDB) is 1 condition that is under investigation as a contributor to symptom burden (6), morbidity, and mortality in patients with chronic HF (5, (7) (8) (9) . The prevalence of comorbid SDB in patients with HF is high, at 47% to 76% (10) (11) (12) (13) (14) . SDB is characterized by 2 different abnormal breathing patterns:
obstructive sleep apnea (OSA) and central sleep apnea (CSA) with Cheyne-Stokes respiration (CSR). The prevalence of OSA was reported to be higher in patients with chronic HF (12% to 43%) than in the general population (15) (16) (17) (18) (19) (20) .
The prevalence of CSA-CSR in patients with chronic HF ranges between 21% and 40% in different studies (10) (11) (12) (13) (14) . Furthermore, both OSA and CSA-CSR have been shown to be markers of disease severity and predictors of increased mortality in chronic HF (8, (21) (22) (23) (24) (25) .
In general, the reported prevalence of SDB in chronic HF is based on either single-center or smallscale studies. To date only 1 multicenter study has been reported (12) , and just 5 single-center studies enrolling $100 participants have been published (10) (11) (12) (13) (14) . Furthermore, in all previous studies, women were a minority of participants, which does not allow robust sex-specific estimates of SDB prevalence (10) (11) (12) (13) (14) . All samples included highly selected patients with chronic HF who were either hospitalized patients or outpatients from specialist HF clinics (10) (11) (12) (13) (14) 26) . This resulted in populations that were predominantly male and younger than the average patient with chronic HF (2, (26) (27) (28) .
The clinical diagnosis of SDB in patients with chronic HF is difficult because key symptoms and characteristics of patients with SDB and normal cardiac function, such as daytime sleepiness and obesity, are often not present (29, 30 The SchlaHF Registry Data Arzt et al.
The SchlaHF Registry Data the forest plots, they were classified to allow a graphical presentation of the prevalence. Abbreviations as in Table 1 .
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HF. The prevalence of SDB was 36% in women, 49% in men, and 46% overall. The prevalence of SDB increased with age and was numerically higher in males in any age group ( Table 2) . In patients with SDB, mean AHI was higher in men than in women, both overall and in the different age groups ( were not significant ( Figure 1A) . Adjusted SDB prevalence rates by age and sex are shown in Figure 2 . Prevalence of SDB (AHI $15/h) in patients with chronic heart failure by age and sex, adjusted for all other risk factors in the model. Abbreviations as in Figure 1 .
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The SchlaHF Registry Data prospectively enrolled 700 patients (20% female) (11) . SDB was documented in 76% of patients (40% with CSA and 36% with OSA) (11) . Looking at moderate-to-severe SDB (AHI $15/h), the prevalence was 52% (11). Patients with CSA or OSA were older than those without SDB and were more likely to be male. In addition, patients with CSA had more advanced HF symptoms and were more likely to have atrial fibrillation, and those with OSA had a higher BMI and tended to have a higher prevalence of diabetes (11) . The overall prevalence of SDB in another study of 100 male patients with chronic HF was also approximately 50% (10) . In summary, the prevalence rate observed in this large population analysis was lower than that in previous studies that included younger patients with a greater degree of left ventricular dysfunction (10) (11) (12) (13) (14) . The older age and better cardiac function in this trial can probably be explained by the fact that patients were identified through cardiology practices, whereas those in previous studies were mostly recruited or referred from specialized HF clinics in hospitals.
In the Sleep Heart Health Study, Young et al. (20) reported the average age-dependent SDB prevalence in community-dwelling adults age 39 to 99 years. Arzt et al.
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The results showed SDB prevalence, defined as AHI $15/h, increased between 40 and 60 years of age from 6% to 20%, reaching a plateau between age 60 and 70 years. In contrast, we could not find such a plateau effect in our population of patients with chronic HF. Instead there was a continuous increase in SDB prevalence, from 31% in the subgroup age #50 years to 57% in the oldest patients (age >80 (Table 4 ) (13, 14, 26) . Male sex, atrial fibrillation, low awake carbon dioxide pressure, age in general, and age >60 years were independently associated with CSA-CSR (13, 14) . In OSA, both Sin et al. (13) and Yumino et al. (14) demonstrated that BMI was a predictor only in men. However, these 2 studies reported different observations on the role of age; Sin et al. (13) found that age was an independent predictor of OSA in women only, whereas This study has 3 major strengths. First, because of the large sample size, the prospective recruitment of patients by both cardiology practices and hospital cardiology departments, and the use of a portable screening device for SDB instead of PSG, the results are more representative and applicable to contemporary chronic HF population than previous studies (13, 14, 26) . This study cohort is similar to the community chronic HF population described by the first large-scale study in a representative study cohort, it was possible to present age-and sexdependent prevalence and risk factor estimates;
this is in contrast to previous studies (13, 14, 26) .
Third, we could confirm predictors, such as male sex, age, obesity, and atrial fibrillation as reported by previous studies (13, 14) in a larger patient population. Furthermore, this is the first study that presents an independent association between SDB and both severe impairment of systolic cardiac function and higher NYHA functional class.
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